CU
Publicaties op Oncologisch.com
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer ...
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc ...
PlanB studie: adjuvant EC-docetaxel versus docetaxel-cyclofosfamide bij mammacarcinoom
Neoadjuvant nab-paclitaxel plus carboplatine versus nab-paclitaxel plus gemcitabine bij TNBC